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Abstract
Background: Telepathology, which is an emerging form of telemedicine in Canada, is defined as the electronic
transmission of pathological images, usually derived from microscopes, from one location to another. There are
various applications of telepathology, including case referral for an expert opinion, provision of an emergency
service in the absence of a resident pathologist, and education. Until now, there has been relatively little use of
telepathology for core diagnostic services in the absence of a local pathologist, but this practice is likely to increase
in the future. The Laval University Integrated Health Network is in the process of deploying a telepathology system,
primarily to provide an intraoperative frozen section service to small hospitals in sparsely populated areas which
are experiencing a severe shortage of on-site pathologists. The telepathology project involves 17 hospitals located
in five regions of eastern Quebec, Canada. This paper describes the study protocol that will be used to evaluate
the benefits associated with the project.
Methods/Design: A panel of experts was first assembled by Canada Health Infoway to agree on a set of benefits
indicators that could be applied to all telepathology projects across Canada. Using the set of indicators as an input,
we have developed a three-step study protocol. First, a survey questionnaire will be distributed to appraise the
way pathologists, pathology technologists and surgeons perceive the telepathology system and its impacts.
Second, a series of semi-structured interviews will be conducted with project leaders and telepathology users at
sites that are representative of all the hospitals in the Laval University Integrated Health Network. The overall aim is
to better understand the expected and unexpected effects of telepathology on health care professionals and
patients as well as on the regional organization and delivery of care services. Finally, a pre-post design using
secondary data is proposed to evaluate a wide array of tangible benefits to the patients, the health care providers,
the hospitals, and the region as a whole.
Discussion: The Laval University Integrated Health Network’s telepathology project is expected to yield positive
and significant results that are relevant internationally. Our findings will provide valuable information on the nature
and extent of benefits associated with telepathology systems intended to provide an intraoperative frozen section
service to remote hospitals experiencing a shortage of specialists.
Background
Pathology is a scientific field concerned with the study
of the nature and causes of diseases. Anatomic pathol-
ogy, which is at the heart of this paper, is a medical spe-
cialty concerned with the diagnosis of diseases based on
the gross, microscopic, chemical, immunologic, and
molecular examination of org a n s ,t i s s u e s ,a n dw h o l e
bodies (autopsies). Because pathology examinations
serve as the basis for a large percentage of decisions
about diagnosis, treatment, hospital admission, and dis-
charge, their annual number have increased in recent
years in step with health care demand and, ultimately,
with population growth and demographic aging. While
an increase in the supply of pathologists would appear
to be essential to maintaining patient care, the number
of pathologists has declined in many developed coun-
tries over the last decade. This has been the case in
Japan [1,2], Australia [3], the UK and New Zealand [4],
as well as Canada [5], to name a few. In the province of
Quebec - the site of our study - the supply of patholo-
gists fell 10% from 1998 to 2008 [5]. Moreover,
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dents [6], making it even more difficult to reverse this
trend.
A shortage of pathologists has several consequences.
The most direct is a longer turn-around time before a
diagnosis can be made on a specimen [7]. Knowing that
in the case of cancer - an area where pathology diag-
noses are crucial - prompt diagnosis/treatment is parti-
cularly important, the repercussions of this labor
shortage can be dramatic. The shortage also influences
workload and quality assurance. When there are fewer
people to do a job, workers become overloaded and it is
difficult to guarantee good quality [6,8]. Finally, because
o ft h es h o r t a g em a n yp a t h o logists are compelled to
work past retirement age, and this may add to the over-
all quality problem. Once purely theoretical, such conse-
quences were confirmed in recent years when news
accounts about errors in anatomic pathology testing
began to make national headlines. In addition to this
shortage, pathology is gaining in complexity and pathol-
ogists working alone increasingly require support from
colleagues. It is estimated that 10 to 20% of oncology
cares require a second opinion [9].
One way to counteract the scarcity of pathologists and
help them obtain a second opinion is to adopt tele-
pathology, which is defined as the practice of pathology
at a distance. Telepathology uses telecommunications
technologies to facilitate the transfer of image-rich
pathology data between distant locations for the pur-
poses of diagnosis, education, and research [10]. Tele-
pathology is performed in three modes: static, dynamic,
and hybrid. When a pathologist is reviewing one or sev-
eral preselected still images, he is working in static
mode (also known as store-and-forward). In contrast,
when a pathologist examines images while communicat-
ing live with the remote site where the specimen is
located, he is working in dynamic mode. Finally, when-
ever a pathologist uses both methods to provide a diag-
nosis, he is working in hybrid mode [11].
Microscopic static examinations work well when there
is no ambiguity as to the images the laboratory technol-
ogist should submit to the pathologist [12]. A micro-
scopic dynamic examination involves the use of a
robotized remote-controlled microscope by the patholo-
gist to explore an entire slide surface, change the magni-
fication level, or focus on and digitize a portion of
interest. The glass slide is usually prepared by a well-
trained laboratory technologist who must also position
it within the microscope [13]. A macroscopic (or gross)
dynamic examination is performed when the pathologist
can first look at the whole specimen (e.g., tumour,
organ, etc.) and talk to the technologist to orient the
cuts. The histological section is then fixed on a glass
slide and completely digitized by a slide scanner to
provide a virtual slide of outstanding quality that can be
remotely accessed and examined [14]. Virtual slides, as
they are called, therefore constitute a newer form of
microscopic static examination.
Once installed, a telepathology system can be used for
distant primary diagnoses, expert referrals, quality assur-
ance, and education [12]. For distant diagnoses in the
absence of a local pathologist or a telepathology system,
slides must be physically sent to another facility, hence
delaying the diagnoses. With telepathology, the slides
are examined remotely, either statically or dynamically,
and diagnoses are swiftly provided. In some particular
instances, however, pathology examinations are per-
formed while the patient is still under anaesthetics and
undergoing surgery, and the surgeon needs a pathology
diagnosis to properly resume his procedure. For these
specific examinations, called intraoperative frozen sec-
tions, delays are undesirable. When there is no local
pathologist in a hospital and a surgical procedure
requires an intraoperative frozen section examination,
either the patient is transferred to another hospital, a
visiting pathologist is called on site, or a procedure is
performed in two steps (creating time for the slides to
be sent and read elsewhere).
With telepathology, intraoperative frozen section ana-
lyses can be performed whenever a pathologist is avail-
able at a remote location. The procedure usually unfolds
as follows: a laboratory technologist manipulates the
specimen locally while it is filmed; a pathologist per-
forms a gross examination of the specimen from
another location examining the specimen and interact-
ing with the technologist via a monitor and tells her
where to cut; the technologist prepares one or more
slides from the section then digitizes and stores them in
a repository; and the pathologist accesses the images,
performs his examination and provides his diagnosis
directly to the surgeon by phone. The present study
focuses specifically on this hybrid telepathology service:
intraoperative frozen section examinations of virtual
slides.
Examinations of intraoperative frozen sections have
been performed via telepathology for over 20 years. In
1989, a Norwegian hospital decided to cover another
facility located 400 km away using a motorized video-
microscope that could be remotely controlled. The pro-
ject was then expanded to four other hospitals [15]. In
Japan, where experiments with telepathology began in
1982, intraoperative rapid diagnosis has been intensively
used since the early 1990’s to alleviate the effect of a
severe shortage of pathologists - only 0.7% of the total
number of physicians in Japan are pathologists [1]. In
the United States, a fully implemented telepathology ser-
vice was introduced between Veterans Affairs Medical
Centers in Milwaukee (Wisconsin) and Iron Mountain
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other things, to examine intraoperative frozen section
cases at Iron Mountain, which has had no on-site
pathologist since that time [16]. In Canada, pathologists
from the University Health Network (UHN) started
using telepathology to examine frozen sections in 2004.
More precisely, pathologists located at the Toronto
General Hospital cover for Toronto Western Hospital
and its affiliated Neuroscience Center.
We conducted a scoping review [17] to identify the
nature and extent of telepathology research evidence.
First, we searched two databases (PubMed and ABI
Inform) with the keyword “telepathology” to obtain a
general sense of the existing research on this topic. We
chose these databases because we felt that they were
offering a good sample of knowledge dissemination
within the medical field (PubMed) as well as the busi-
ness field (ABI Inform). Our queries, performed on Sep-
tember 9, 2011, resulted in 763 citations (730 found in
PubMed, 25 found in ABI Inform and 8 found in both
databases.) The titles and abstracts of these articles were
skimmed and they appeared to be predominantly valida-
tions of the diagnostic accuracy of telepathology sys-
tems. At that point, we added the keyword “frozen
section” to our search algorithm, as our study focuses
on this type of examination. Our revised queries
resulted in 72 citations (68 found in PubMed, three
found in ABI Inform and one found in both databases).
Four of these articles were excluded: three were not in
English or French and one could not be found through
our interlibrary system. Of the remaining 68 articles, 38
were concerned with diagnostic accuracy (19 of these
articles also examined the time spent to arrive at these
diagnoses), 10 were general papers introducing the
topic/technology, nine were qualitative research on mat-
ters such as organizational consequences, learning, and
cooperation in setups where telepathology was used
(seven of them were subsections of a single research
project by a single author), four were technical papers
related to specific systems/features, and two were
descriptive case studies presenting projects without eval-
uating them. Finally, only two articles were looking at
the outcomes of telepathology, which is at the heart of
our project. This literature dates back to 1991 when the
first papers on the Norwegian installations were
published.
According to Drummond et al. [18], evaluations must
first be carried out on efficacy (can this theoretically
work?), effectiveness (does this work in practice?), and
availability (is this accessible to those who need it?)
before an in-depth economic evaluation can be per-
formed. The results of our scoping review confirm this
evolution and suggest that the field is mature enough
for more benefit assessments, economic or not. In this
line of thought, the primary objective of this study is to
evaluate the benefits of a major regional telepathology
project implemented in 17 health care organizations
located in eastern Quebec, Canada. The main goal of
the project is to allow remote analysis of intraoperative
frozen sections, although the telepathology system in
place can also be used for other purposes, including sec-
ondary opinions and education sessions. As explained
below, expected benefits encompass quality, access and
productivity outcomes and will be measured at both the
local and regional levels.
Our evaluative approach is based on DeLone and
McLean’s information systems success model, illustrated
in Figure 1. According to this framework, the individual
benefits of an information system are derived from
expressed satisfaction with the system and its use, which
are in turn influenced by three factors: the perceived
quality of the system, the perceived quality of the infor-
mation contained in the system, and the perceived qual-
ity of the technical and organizational support offered.
Finally, the greater the benefits at the individual level,
the more the positive effects associated with use of the
new system will be felt at the organizational and regio-
nal levels [19-21].
Methods/Design
Setting and project
The province of Quebec counts 7.9 million inhabitants
and its health system is public. The health system is
divided into four regions, each under the responsibility
of a different University Integrated Health Network
(UIHN). The mandate of each UIHN is to coordinate
tertiary health care services, teaching and research pro-
vided by its faculty of medicine and its associated teach-
ing hospitals so as to improve access to health care by
streamlining relationships between primary care provi-
ders - doctors and regional hospitals - and upper-level
care providers for specialized procedures. Each UIHN is
also responsible for coordinating technology evaluation
and health intervention methods in order to improve
Figure 1 Conceptual Framework (from DeLone and McLean,
2003).
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Quebec Health Ministry asked each UIHN to submit a
business case for a major regional telehealth project.
The Laval University Integrated Health Network (here-
inafter called the Laval UIHN) proposed a telepathology
project, which is described next.
The telepathology project involves 17 hospitals located
in 5 geographic regions of eastern Quebec, Canada [22].
The area covered by the project accounts for approxi-
mately 19% of the province’s total population and the
territory spans 378,037 km
2 (approximately the size of
Germany). Its population density is quite low. Figure 2
illustrates the province of Quebec and the area covered
by the telepathology project, and Table 1 presents more
information on the different regions.
At the beginning of 2010, six of the 17 hospitals had
no pathology laboratory and seven hospitals had a
laboratory but were functioning with 0, 1 or 1.25 full-
time equivalent pathologists (see Table 2). All 17 hospi-
tals had surgeons who could execute procedures requir-
ing intraoperative frozen section analyses. For these
procedures to be performed where there was no on-site
pathologist, four courses of actions were possible: (1) a
visiting pathologist could be appointed, (2) the patient
could be transferred to another hospital, (3) the opera-
tion could be completed in two stages (the specimen
would be transported and analyzed elsewhere and the
patient would be reopened if the diagnosis was positive),
or (4) the surgery could be performed more aggressively
(i.e. by removing more of the organ in order to “play it
safe”).
In 2006, the Laval UIHN decided to invest in a large
telepathology project to offer the population in periph-
eral, intermediary and remote regions improved access
and continuity with respect to specialized services. The
CAN$6.2 million project is financed by the Quebec
Health Ministry and Canada Health Infoway, an inde-
pendent not-for-profit corporation that works as a stra-
tegic investor of funds provided by the Canadian
government. In May 2011, the status of the project was
as follows: the equipment had been delivered, physically
installed and configured, and biomedical technicians,
laboratory technologists and pathologists had been
trained at 14 of the 21 sites. The equipment had been
delivered, physically installed and configured but train-
ing had not been given at five other sites, mainly the
ones that had to build a pathology laboratory before
receiving the equipment. Finally, at the last site, the
equipment had been delivered but further steps were
delayed because the building posed a security risk,
according to a recent seismic study. The equipment
delivered to each site comprised a slide scanner (Nano-
zoomer, Hamamatsu Photonics, Shizuoka Prefecture,
Japan), a macroscopic imaging station (Pathstand 40,
Diagnostic Instruments, Sterling Height, USA), visualiza-
tion and communication software (mScope, Aurora
Interactive Ltd., Montreal, Canada), computer stations,
and storage servers.
As mentioned above, the main applications for tele-
pathology are distant primary diagnosis, expert referrals,
and education [12]. The Laval UIHN’sp r i o r i t yi nt h i s
project is to have the telepathology system used for
intraoperative examinations and, to a lesser extent,
expert referrals, although utilization for other purposes
(quality assessment, education, etc.) is not forbidden.
Lastly, an important feature of the Laval UIHN project
is the absence of a core laboratory to provide telepathol-
ogy services to each facility involved. Instead, each hos-
pital had to enter into a partnership agreement with one
or more facilities of their choice and test their config-
urations (hardware, software and telecommunication
links.) Ultimately, each hospital should be linked to
every other hospital, which would make a rotating 24-
hour schedule feasible.
Research design
This study uses a mixed method design that integrates
case studies, survey questionnaires and a quantitative
pre-post evaluation. As a first step, a panel of experts
was assembled by the Benefits Realization and Quality
Figure 2 Regions Underserved by the Laval UIHN in Eastern
Quebec, Canada.
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Region 1 Region 3 Region 9 Region 11 Region 12
Bas-Saint-Laurent Capitale Nationale Côte-Nord Gaspésie-Îles-de-la-Madeleine Chaudière-Appalaches
Type Intermediary University Remote Remote Peripheral
Population 201,135 695,262 96,001 94,243 406,596
Area (km
2) 22,405.07 19,285.71 300,281.83 20,937.69 15,128.14
Population density (per km
2) 8.98 36.05 0.32 4.50 26.88
Table 2 Profile of the Sites Involved in the Laval UIHN’s Telepathology Project
Region Type Location of
the site
Distance from CHUQ’s
central laboratory
Presence of a
pathology
laboratory
Number of
pathologists on
site
Status in May 2011
1
Bas-Saint-Laurent
Intermediary Rimouski 313 km Yes 2 Equipment installed and
training completed
Rivière-du-
Loup
206 km Yes 1.25 Equipment installed and
training completed
3
Capitale
Nationale
University Quebec City
CHUQ - HD
0 Yes 15* Equipment installed and
training completed
Quebec City
CHUQ -
CHUL
8.4 km Yes Equipment installed and
training completed
Quebec City
CHUQ - HSFA
3.3 km Yes Equipment installed and
training completed
Quebec City
CHAUQ - HSS
3.3 km Yes 12* Equipment installed and
training completed
Quebec City
CHAUQ - HEJ
3.6 km Yes Equipment installed and
training completed
Quebec City
Hôpital Laval
8.1 km Yes 3 Equipment installed and
training completed
La Malbaie* 145 km No 0 Equipment installed and
training completed
Baie-Saint-
Paul*
93 km No 0 Delivered
9
Côte-Nord
Remote Sept-Îles 672 km Yes 0 Equipment installed and
training completed
Baie-Comeau 444 km Yes 1 Equipment installed and
training completed
11
Gaspésie-Îles-de-
la-Madeleine
Remote Gaspé 687 km Yes 1 Equipment installed and
training completed
Chandler 720 km No 0 Equipment installed
Saint-Anne-
des-Monts
494 km No 0 Equipment installed
Les-Îles-de-la-
Madeleine
1,153 km No 0 Equipment installed
Maria 587 km No 0 Equipment installed
12
Chaudière-
Appalaches
Peripheral Lévis 31.3 km Yes 3 Equipment installed and
training completed
Saint-Georges 107 km Yes 1 Equipment installed and
training completed
Thedford
Mines
111 km Yes 0 Equipment installed and
training completed
Montmagny 80 km Yes 1 Equipment installed and
training completed
* Numbers provided for the merged organization
** These two sites account for one hospital (CH Charlevoix)
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This panel consisted of 26 people engaged in various
telepathology projects across Canada. Panel members
either were pathologists, laboratory technologists, or
independent academic researchers. The goal of this
panel was to agree on a set of indicators that could be
applied to most Canadian telepathology projects. The
panel met via teleconference once a month for 4
months in order to share opinions. As mentioned
before, the theoretical framework driving the effort was
DeLone and McLean’s information systems success
model [19,21]. The final list of indicators, shown in
Table 3, was approved in May 2011.
Our evaluation will be conducted in two separate
phases. Phase 1 will focus on individual perceptions and
will be divided into two parts. First, a survey question-
naire has been developed to appraise how users perceive
the telepathology system and its impacts. The question-
naire was adapted from a recent digital medical imaging
evaluation study that used the same framework as a
conceptual foundation [23]. Questions were reformu-
lated to reflect the different systems, work processes and
settings and confirm the instrument’s validity. Three
versions of the questionnaire instrument are now ready
to be pre-tested with a small group of pathologists (ver-
sion 1), pathology technologists (version 2) and surgeons
(version 3) who have been involved in telepathology
projects elsewhere in Canada. Following the pre-test, a
final version of each instrument will be prepared and
gradually administered to all the pathologists (N = 48),
pathology technologists (N = 60), and surgeons (N = 30)
involved in the Laval UIHN project. Questionnaires will
be distributed approximately 6 months after the “go
live” at each site.
As a second step, a series of semi-structured inter-
views will be conducted concurrently with both project
leaders and telepathology users at sites representative of
all types of establishments - remote, intermediary, and
teaching hospitals. The overall goal is to better under-
stand the effects of telepathology on health care profes-
sionals, patients, and the overall organization and
delivery of care services in different types of organiza-
tions. The data collection process will continue until
theoretical saturation [24] is reached; i.e. when addi-
tional qualitative data no longer contributes anything
new about the constructs in our conceptual framework
and the relationships among them. Interview guides
containing the specific issues to be discussed with the
pathologists, pathology technologists, and surgeons were
developed and will be used at each interview. Table 4
synthesizes the key constructs to be investigated with
each group of respondents in Phase 1.
While Phase 1 is concerned with users’ perceptions,
Phase 2 will allow us to evaluate objective or factual
benefits to the hospitals (e.g., a decrease in the number
of cancelled surgical procedures due to pathology-
related issues), the patients (e.g., a decrease in the aver-
age time between a medical diagnosis and a first surgical
intervention) and the UIHN as a whole (e.g., a decrease
in the number of patients transferred to a regional or
tertiary hospital for surgery). To achieve this, pre-post
analyses will be performed using data from different
information systems - i.e. laboratory information sys-
tems, operating room information systems, and tele-
pathology visualization and communication systems -
available at each hospital. More specifically, data from
these systems will be obtained for two 6-month periods:
post implementation data will be obtained for the six
first months after system deployment, and pre imple-
mentation data will be gathered for the corresponding 6
months of the previous year.
Given the exploratory nature of our study, it was
decided to limit our sample to two specific procedures:
sentinel lymph node analyses for breast cancer and sur-
gical margin analyses for colorectal cancer. According to
the Laval UIHN authorities, these procedures are among
the most common ones requiring intraoperative frozen
section diagnoses. In order to capture a broad range of
effects, both anticipated and unanticipated, and to better
understand the nature of the effects according to the
context, our pre-post analysis will be conducted in three
different settings. First, we will investigate a remote hos-
pital where telepathology was deployed in order to avoid
a break in services; the on-site pathologist left between
the pre and post periods (thereby leaving the site with
no pathologist). Our second setting is a remote hospital
where pathology services were nonexistent. With the
arrival of telepathology, a mini-laboratory was installed
at this site, and a pathology technologist was trained so
that medical interventions requiring pathology services
could now be provided. Finally, we will investigate the
effects of telepathology at a regional hospital where a
number of pathologists left between the pre and post
periods without being replaced, causing breaks in
services.
Data analysis
The psychometric properties of our survey measures will
be assessed first. For one thing, the reliability and con-
struct validity of all scales will be measured. One inter-
pretation of the reliability criterion is the internal
consistency of a test, i.e. the extent to which the items
are homogeneous [25]. In this sense, reliability refers to
the accuracy or precision of a measuring instrument.
This will be tested by calculating a Cronbach’s alpha for
each construct. Convergent validity refers to whether
the items comprising a scale behave as if they are mea-
suring a common underlying construct. Hence, in order
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Construct
Dimension Question
SYSTEM QUALITY
Ease of use Generally speaking, the telepathology system is easy to use.
It is easy to master the telepathology system functionalities.
The graphical interfaces of the telepathology system are clear and easy to understand.
It is easy to find slides from the other facilities in the telepathology system.
It is easy to send slides and information to other facilities using telepathology.
Screen quality The PC screens available in our facility are of acceptable quality.
The screens dedicated to the telepathology system are of acceptable quality.
The quality of the screens encourages me to use the telepathology system.
Systems integration The telepathology system and the laboratory information system (LIS) are well integrated.
The telepathology system, the LIS and the dictation subsystem are well integrated.
Joint use of the telepathology system/LIS/dictation subsystem makes the work easier.
When the data on a patient come from different facilities, the telepathology/LIS systems provide well-integrated
information.
When the data on a patient come from different facilities, the telepathology system/LIS/dictation subsystem
provide well-integrated information.
Reliability The telepathology system is rarely offline because of technology breakdowns.
Unexpected service outages of the telepathology system rarely occur.
Use of the telepathology system is uninterrupted because it is bug-free.
Accessibility We have a sufficient number of telepathology work stations.
I have rarely had to wait for access to a work station in order to use the telepathology system.
I have easy access to the telepathology system from my home computer.
Response time I have the impression that slides are digitized quickly.
I have the impression that the macroscopic images are fluid.
I have the impression that the microscopic images download quickly.
We have quick access to images from other facilities.
Setting aside image acquisition, the telepathology system responds quickly.
Perceived Usefulness Overall, the telepathology system provides a complete range of functionalities that support my work as a
professional.
My clinical practices are very well harmonized with the telepathology system.
Using the telepathology system is compatible with all aspects of my tasks.
INFORMATION QUALITY
Data quality The slide images produced locally in my facility are:
￿ Complete
￿ Reliable and precise
￿ Well organized and carefully presented
￿ Available in a timely manner
￿ Secure and confidential
The slide images produced externally in other facilities are:
￿ Complete
￿ Reliable and precise
￿ Well organized and carefully presented
￿ Available in a timely manner
￿ Secure and confidential
SERVICE QUALITY
Technical support The pilots or super-users in my hospital who provide technical assistance for the telepathology system:
￿ Are easy to reach
￿ Provide quick service
￿ Are competent
￿ Pay attention to user needs
￿ Are able to find satisfactory solutions
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The staff from the regional support centre who provide technical assistance for the telepathology system:
￿ Are easy to reach
￿ Provide quick service
￿ Are competent
￿ Pay attention to user needs
￿ Are able to find satisfactory solutions
Training I am satisfied with the training I received on using the telepathology system.
I learned how to use the telepathology system properly because of the training I received.
I apply what I have learned during my training on the telepathology system.
I can better use the telepathology system because of the training I received.
USER SATISFACTION
Overall, my experience using the telepathology system has been satisfactory.
I enjoy using the telepathology system in my work.
Overall, examining digitized slides on a monitor is more satisfying than examining glass slides with a microscope.
Being able to obtain a second opinion via the telepathology system satisfies me greatly.
Being able to perform intraoperative frozen section analyses via telepathology satisfies me greatly.
Being able to obtain an intraoperative rapid diagnosis via telepathology satisfies me greatly.
Being able to use the telepathology system for immunohistochemistry cases satisfies me greatly.
USE
Breadth I use a wide range of the telepathology system’s functionalities.
Type How often do you...
...use the telepathology system to fulfill your functions?
...use the telepathology system to get/provide a second opinion?
...use the telepathology system to get/provide a intraoperative frozen section diagnosis?
...use the telepathology system for immunochemistry cases?
BENEFITS
Individual impacts Using the telepathology system improves the quality of my diagnoses.
The telepathology system improves my confidence level when I perform some surgical procedures.
Some of my surgical procedures are less invasive because of the telepathology system.
Using the telepathology system saves me some of the time I used to spend moving about.
The telepathology system reduces my sense of professional isolation.
Organizational
impacts
Quality The telepathology system’s tracking mode reduces the risk of medical errors.
The quality of patient care is improved because of the telepathology system.
Efficiency The telepathology system reduces the time between a surgical procedure and the availability of a preliminary
report.
The telepathology system reduces the time between the moment a slide is available for reading and the final
diagnosis.
Effectiveness The telepathology system reduces the number of surgical procedures postponed due to a lack of pathologists.
The telepathology system reduces the number of surgical procedures performed in two stages.
Retention/
Recruitment
The telepathology system helps retain workers from different pathology professions (pathologists, pathology
technologists, etc.) in our facility.
The telepathology system helps recruit workers in different pathology professions for our region.
The telepathology system makes the various pathology professions more attractive.
Regional impacts Accessibility The telepathology system has improved the accessibility of pathology services.
The pathology coverage rate is improved because of telepathology.
Fewer patients are transferred to regional or tertiary sites because of telepathology.
Continuity Patients enjoy improved continuity of care because of telepathology.
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the same construct (i.e. a trait) should be highly corre-
lated with one another [25]. Discriminant validity is
concerned with the ability of a measurement item to dif-
ferentiate between the concepts being measured. We
will thus compare the square root of the variance shared
by the constructs and their measures to the correlations
between the constructs. Following this assessment of the
measurement model, descriptive statistics will be com-
puted and the associations presented in Figure 1 will be
tested using linear stepwise regression analyses. Statisti-
cal tests will also be performed to determine whether
significant differences can be found by type of institu-
tion (local, regional, university) and type of health care
professional (pathologists, technologists, surgeons.)
Given our small sample size, non-parametric tests such
as Kruskal-Wallis and Mann-Whitney will be performed.
The SPSS statistical package will be used to run these
analyses at a 5% significance level.
As for the qualitative data, interview transcripts and
observation notes will be analyzed using the NVivo soft-
ware package. The constructs in our conceptual frame-
work (Figure 1) will be critical to developing our coding
scheme and interpreting the qualitative material [26].
Open coding will also be performed so that any unfore-
seen themes that might emerge from the data will also
be captured [27]. It is worth mentioning that, in order
to increase reliability, all interviews will be coded by two
researchers.
Lastly, a paired two-sample test of means (t-test) will
be conducted to determine whether any differences
found between pre and post measures are significant
(based on the list of indicators in Table 5). Given that
two common procedures were selected for the pre-post
analyses, we expect our sample size to be large enough
to allow the use of a parametric test.
Ethics considerations
This research project has been assessed with regard to
the ethical conduct for research involving humans and
meets the requirement of HEC Montréal’s Research
Ethics Board. A notice has been issued to this effect on
December 14, 2011.
Discussion
In the last 30 years, the number of telemedicine applica-
tions has multiplied due to advancements in telecom-
munications. One of these applications, telepathology,
has fostered considerable academic research since the
mid-1980s. The extant literature has mainly followed
the path described by Drummond et al. [18], and eva-
luations have so far been carried out on reliability, effi-
cacy, effectiveness, and availability [e.g., [12,28]]. For
frozen section examinations, the accuracy of the techni-
que has been demonstrated [e.g., [29,30]] as has its
speed [e.g., [14,31]]. However, very few empirical studies
have evaluated the benefits of telepathology at the
patient, provider, organizational and regional levels.
Table 4 Constructs and Categories of Respondents
Constructs Pathologists Technologists Surgeons
Information quality X
System quality X X
Service quality X X
Use X X
Intention to use X X
User satisfaction X X X
Net benefits X X X
Table 5 Key Indicators for the Pre-Post Analyses
Usage types Indicators
Second opinions Number of second opinions sought
Average delay between the request for a second opinion and its reception
Intraoperative frozen section
analyses
Number of intraoperative diagnoses performed/number of surgical procedures performed
Number of surgical procedures performed at the local or regional site
Number of cancelled surgical procedures due to pathology related issues
Number of surgical procedures performed in two stages
Number of patients transferred to a regional or a tertiary hospital for surgery
Coverage rate of in situ pathologists
Coverage rate of visiting pathologists
Average time between a medical diagnosis and a first surgical procedure
Average time between a surgical procedure and a preliminary pathology report
Average time between the moment the slide is ready to be read and the final pathology diagnosis is
provided
Trudel et al. BMC Health Services Research 2012, 12:64
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Page 9 of 11Using a mixed-method design that combines qualita-
tive and quantitative data collection methods, the pre-
sent study attempts to fill this gap. More specifically,
our research will add to the extant body of knowledge
by offering a thorough evaluation of a large telepathol-
ogy project, assessing outcomes at multiple levels of
analysis. To our knowledge, our study will be the first to
examine a regional telepathology project by focusing on
intraoperative frozen section analyses. Our study will
also be the first to perform an exhaustive pre-post eva-
luation using secondary data from operating room and
other health information systems. By drawing a clearer
picture of the benefits to be obtained by deploying a
large regional telepathology project, our study should
help decision makers and regional authorities redistri-
bute regional workforces around optimal workflows that
take advantage of telepathology. Ultimately, positive
results should influence health policy decisions targeted
at broader societal and environmental issues.
Notwithstanding these anticipated contributions, our
study protocol has limitations and, hence, more research
will be needed to further explore the implications of our
work. For one thing, we must acknowledge the usual
limitations on generalizability associated with collecting
data through mail questionnaires as well as the cross-
sectional nature of Phase 1. Significantly, even though
we will be able to compare contrasting situations by
investigating a wide variety of settings in Phase 2, the
fact remains that this research is limited to the study of
a single telepathology project and our results will be
context-dependent. Indeed, the province of Quebec has
its own specificities in terms of the healthcare system
(public), density of population (medium to very low),
physicians’ remuneration mode (fee-for-service) and
pathologist shortage (moderately severe). Therefore,
more evaluative studies will need to be conducted in
other regions or countries to enhance the generalizabil-
ity of our findings.
To our knowledge the ongoing telepathology project
at the Laval UIHN is unique in Canada and is expected
to yield significant results that are relevant both nation-
ally and internationally. Results will provide valuable
information to healthcare managers and decision makers
who must find more effective and efficient ways to pro-
vide accessible care services to patients and, more speci-
fically, patients living in rural regions. A demonstration
of both perceived and actual impacts will likely contri-
bute to the promotion of telepathology at the individual
(patient and provider), organizational and regional
levels. We hope that the study protocol provided here
will guide other researchers interested in evaluating
such projects and contribute to the overall development
o fas o l i dk n o w l e d g eb a s er e g a r d i n gt h er a n g eo f
benefits associated with telepathology in health care
organizations.
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